Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg

NCT03405597 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03405597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Unknown status
Start date
March 30, 2017
Completion date
June 30, 2018
Enrollment
97 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, hbsag, hepatitis b vaccine